Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study

OBJECTIVE: To investigate the efficacy and tolerability of the anti-diabetic agent acarbose (Glucobay(®)) as add-on or monotherapy in a range of patients with type-2 diabetes mellitus (T2DM), including those with cardiovascular morbidities in India. MATERIALS AND METHODS: This was a part of a prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Philip, Elizabeth, Sundaram, Meenakshi L., Das, Rupam, Chauhan, Sushil Kumar, Deshpande, Sandeep, Ambhore, Sanjay, Rathod, Rahul, Manjrekar, Pravin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046615/
https://www.ncbi.nlm.nih.gov/pubmed/24910836
http://dx.doi.org/10.4103/2230-8210.123565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046615/
https://www.ncbi.nlm.nih.gov/pubmed/24910836
http://dx.doi.org/10.4103/2230-8210.123565

Ejemplares similares